In this episode, SpendMend colleagues Jasmine and Megan provide some grantee CE perspectives concerning the HRSA DRL.  They have so much great insight, we are breaking this conversation up into two parts. Stay tuned for Part 2 next week!
In the intro, Rob and Greg discuss thoughts around responding to manufacturer 340B inquiries.

In this episode, SpendMend colleagues Jasmine and Megan provide some grantee CE perspectives concerning the HRSA DRL. They have so much great insight, we are breaking this conversation up into two parts. Stay tuned for Part 2 next week! In the intro, Rob and Greg discuss thoughts around responding to manufacturer 340B inquiries.

In this episode, SpendMend colleagues Jasmine and Megan provide some grantee CE perspectives concerning the HRSA DRL.&nbsp; They have so much great insight, we are breaking this conversation up into two parts. Stay tuned for Part 2 next week!
In the intro, Rob and Greg discuss thoughts around responding to manufacturer 340B inquiries.

Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 1

Pharmacists and healthcare industry leaders Rob ‘Hoopi’ Nahoopii PharmD, MS, ACE and Greg Wilson PharmD, BCPS, ACE dive deeply into the complicated and contentious 340B Program as well as other pressing Pharmacy matters. Special guests and industry experts pop in frequently to add insights from all sides of the discussion. If you serve in the pharmacy sector, this podcast is a must-listen!

Share Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 1

Sign up to save your podcasts

Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 1

Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 1

More shows like 340B Unscripted

WSJ What’s News

Stuff You Should Know

Hidden Brain

The Daily

Up First from NPR

Consider This from NPR

340B Insight

SmartLess

The Ezra Klein Show

Pharmacy Innovators Podcast

New Heights with Jason & Travis Kelce

Pillr Unpacked

The Headlines

Inside 340B Report

Not Gonna Lie with Kylie Kelce